Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from OneSource Specialty Pharma Limited ( (IN:ONESOURCE) ) is now available.
OneSource Specialty Pharma Limited has released its earnings presentation for the second quarter of the fiscal year 2026. The announcement, made after a board meeting, highlights the company’s financial performance and strategic direction, which may influence its market positioning and stakeholder interests.
More about OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, operates in the pharmaceutical industry, focusing on specialty pharmaceuticals. The company is involved in the development and manufacturing of pharmaceutical products, catering to various market needs.
Average Trading Volume: 4,046
Technical Sentiment Signal: Strong Sell
Current Market Cap: 203.3B INR
For detailed information about ONESOURCE stock, go to TipRanks’ Stock Analysis page.